When Should Heart Failure Treatment Be Down-Titrated or Stopped?

ABSTRACT:

CLINICAL CONTEXT

When Should Heart Failure Treatment Be Down-Titrated or Stopped?

This expert-led session explores a practical question in heart failure with reduced ejection fraction. It is designed to support a structured clinical discussion around evidence-based care, patient status and appropriate follow-up.

The video should be interpreted alongside current guidelines, local protocols and the individual circumstances of each patient.

SYNOPSIS

A practical reflection on when and how heart failure treatment may need to be reviewed, reduced or interrupted.

Prof. Alexander Mebazaa

FEATURED SPEAKER

Prof. Alexander Mebazaa

Department of Anesthesiology and Critical Care, University Hospital Saint Louis & Lariboisière Université, Paris, France

IN THIS VIDEO

Key clinical perspectives

  • Clarifying why a change is considered
  • Reviewing the wider clinical picture
  • Supporting individualised care planning

This video is intended for healthcare professionals and supports clinical education. It does not replace individual clinical judgement or local guidance.